Connection
Wells Messersmith to TNF-Related Apoptosis-Inducing Ligand
This is a "connection" page, showing publications Wells Messersmith has written about TNF-Related Apoptosis-Inducing Ligand.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.108 |
|
|
|
-
Wainberg ZA, Messersmith WA, Peddi PF, Kapp AV, Ashkenazi A, Royer-Joo S, Portera CC, Kozloff MF. A phase 1B study of dulanermin in combination with modified FOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer. Clin Colorectal Cancer. 2013 Dec; 12(4):248-54.
Score: 0.108